• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国亨廷顿病的现状:一项全国性调查和国家登记分析。

Current Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry Analysis.

机构信息

Department of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.

Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Mov Disord. 2015 Jan;8(1):14-20. doi: 10.14802/jmd.14038. Epub 2015 Jan 13.

DOI:10.14802/jmd.14038
PMID:25614781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4298714/
Abstract

OBJECTIVE

Huntington's disease (HD) is a rare neurological disorder, and its current status in Korea is not well investigated. This study aims to determine the prevalence and incidence of HD and to investigate the clinical features of HD patients in Korea.

METHODS

We estimated the crude prevalence and annual incidence of HD based on the databases of the Rare Diseases Registry (RDR) and the National Health Insurance (NHI). The clinical data of genetically confirmed HD patients was collected from 10 referral hospitals and analyzed.

RESULTS

The mean calculated annual incidence was 0.06 cases per 100,000 persons, and the mean calculated prevalence was 0.38 based on the NHI database. The estimated crude prevalence based on the RDR was 0.41. Of the sixty-eight HD patients recruited, the mean age of onset was 44.16 ± 14.08 years and chorea was most frequently reported as the initial symptom and chief complaint. The mean CAG repeat number of the expanded allele was 44.7 ± 4.8 and correlated inversely with the age of onset (p < 0.001). About two-thirds of the patients have a positive family history, and HD patients without positive family history showed a delay in onset of initial symptoms, a prolonged interval between initial symptom onset and genetic diagnosis and a delay in the age of genetic diagnosis.

CONCLUSIONS

To the best of our knowledge, this is the first study to estimate the prevalence and incidence of HD in Korea and the largest HD series in the Asian population. Our analyses might be useful for further studies and large-scale investigations in HD patients.

摘要

目的

亨廷顿病(HD)是一种罕见的神经退行性疾病,目前在韩国的情况尚未得到充分研究。本研究旨在确定 HD 在韩国的患病率和发病率,并调查韩国 HD 患者的临床特征。

方法

我们根据罕见疾病登记处(RDR)和国家健康保险(NHI)数据库估算了 HD 的粗患病率和年发病率。从 10 家转诊医院收集了经基因确诊的 HD 患者的临床数据并进行了分析。

结果

根据 NHI 数据库计算的平均年发病率为每 10 万人 0.06 例,平均计算患病率为 0.38。根据 RDR 估算的粗患病率为 0.41。在招募的 68 名 HD 患者中,发病年龄的平均值为 44.16 ± 14.08 岁,舞蹈症是最常报告的首发症状和主诉。扩展等位基因的 CAG 重复数平均值为 44.7 ± 4.8,与发病年龄呈负相关(p < 0.001)。约三分之二的患者有阳性家族史,而无阳性家族史的 HD 患者首发症状出现时间延迟,首发症状出现与基因诊断之间的间隔延长,以及基因诊断年龄延迟。

结论

据我们所知,这是第一项在韩国估算 HD 患病率和发病率的研究,也是亚洲人群中最大的 HD 系列研究。我们的分析可能对进一步的研究和大规模的 HD 患者调查有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2a/4298714/0204c96c645d/jmd-8-1-14f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2a/4298714/2ddfd4412976/jmd-8-1-14f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2a/4298714/0204c96c645d/jmd-8-1-14f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2a/4298714/2ddfd4412976/jmd-8-1-14f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf2a/4298714/0204c96c645d/jmd-8-1-14f2.jpg

相似文献

1
Current Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry Analysis.韩国亨廷顿病的现状:一项全国性调查和国家登记分析。
J Mov Disord. 2015 Jan;8(1):14-20. doi: 10.14802/jmd.14038. Epub 2015 Jan 13.
2
Preliminary analysis of Huntington's Disease in South Korea.韩国亨廷顿舞蹈症的初步分析。
J Huntingtons Dis. 2013;2(1):83-7. doi: 10.3233/JHD-120040.
3
Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 Patients.秘鲁青少年型亨廷顿舞蹈病:32例患者的病例系列
Mov Disord Clin Pract. 2022 Dec 2;10(2):238-247. doi: 10.1002/mdc3.13625. eCollection 2023 Feb.
4
Increased 10-Year Prevalence of Huntington's Disease in South Korea: An Analysis of Medical Expenditure Through the National Healthcare System.韩国亨廷顿舞蹈症10年患病率上升:通过国家医疗保健系统对医疗支出的分析
J Clin Neurol. 2023 Mar;19(2):147-155. doi: 10.3988/jcn.2022.0212. Epub 2023 Jan 17.
5
The Impact of Family History on the Clinical Features of Huntington's Disease.家族史对亨廷顿舞蹈病临床特征的影响
J Huntingtons Dis. 2017;6(4):327-335. doi: 10.3233/JHD-170256.
6
Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years.舞蹈症与HIV感染的鉴别诊断使亨廷顿舞蹈病的诊断延误数年。
Brain Sci. 2021 May 27;11(6):710. doi: 10.3390/brainsci11060710.
7
Clinical and Genetic Characteristics Associated With Survival Outcome in Late-Onset Huntington's Disease in South Korea.韩国晚发性亨廷顿舞蹈病生存结局相关的临床与遗传学特征
J Clin Neurol. 2024 Jul;20(4):394-401. doi: 10.3988/jcn.2023.0329. Epub 2024 Apr 2.
8
Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.西班牙亨廷顿舞蹈症的发病率及突变率:9年直接基因检测经验
J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):337-42. doi: 10.1136/jnnp.2004.036806.
9
Survival of Korean Huntington's Disease Patients.韩国亨廷顿舞蹈症患者的存活率。
J Mov Disord. 2016 Sep;9(3):166-70. doi: 10.14802/jmd.16022. Epub 2016 Sep 21.
10
Clinical and genetic characteristics in patients with Huntington's disease from China.中国亨廷顿病患者的临床和遗传特征
Neurol Res. 2016 Oct;38(10):916-20. doi: 10.1080/01616412.2016.1214555. Epub 2016 Jul 29.

引用本文的文献

1
Variation in the reported prevalence of Huntington's disease: a systematic review and guide to interpretation.亨廷顿舞蹈症报告患病率的差异:系统评价与解读指南
J Neurol. 2025 Jul 24;272(8):534. doi: 10.1007/s00415-025-13255-1.
2
Disparities in Huntington's disease care and research.亨廷顿舞蹈症护理与研究中的差异。
Curr Opin Neurol. 2025 Aug 1;38(4):337-342. doi: 10.1097/WCO.0000000000001376. Epub 2025 May 21.
3
Clinical and Genetic Characteristics Associated With Survival Outcome in Late-Onset Huntington's Disease in South Korea.

本文引用的文献

1
Genetic modifiers of Huntington's disease.亨廷顿舞蹈症的基因修饰因子
Mov Disord. 2014 Sep 15;29(11):1359-65. doi: 10.1002/mds.26001. Epub 2014 Aug 25.
2
Onset of Huntington's disease: can it be purely cognitive?亨廷顿舞蹈症的发病:其症状会仅表现为认知方面吗?
Mov Disord. 2014 Sep 15;29(11):1342-50. doi: 10.1002/mds.25997. Epub 2014 Aug 20.
3
Preliminary analysis of Huntington's Disease in South Korea.韩国亨廷顿舞蹈症的初步分析。
韩国晚发性亨廷顿舞蹈病生存结局相关的临床与遗传学特征
J Clin Neurol. 2024 Jul;20(4):394-401. doi: 10.3988/jcn.2023.0329. Epub 2024 Apr 2.
4
Epidemiology of Chronic Inflammatory Demyelinating Polyneuropathy in South Korea: A Population-Based Study.韩国慢性炎性脱髓鞘性多发性神经病的流行病学:一项基于人群的研究。
J Clin Neurol. 2023 Nov;19(6):558-564. doi: 10.3988/jcn.2023.0007. Epub 2023 Jul 20.
5
Increased 10-Year Prevalence of Huntington's Disease in South Korea: An Analysis of Medical Expenditure Through the National Healthcare System.韩国亨廷顿舞蹈症10年患病率上升:通过国家医疗保健系统对医疗支出的分析
J Clin Neurol. 2023 Mar;19(2):147-155. doi: 10.3988/jcn.2022.0212. Epub 2023 Jan 17.
6
Neuroprotective effect of silymarin against 3-Nitropropionic acid-induced neurotoxicity in rats.水飞蓟素对3-硝基丙酸诱导的大鼠神经毒性的神经保护作用。
Curr Res Pharmacol Drug Discov. 2022 Sep 20;3:100130. doi: 10.1016/j.crphar.2022.100130. eCollection 2022.
7
Population Prevalence, Cancer Risk, and Mortality Risk of Turner Syndrome in South Korean Women Based on National Health Insurance Service Data.基于韩国国家健康保险服务数据的韩国女性特纳综合征的流行率、癌症风险和死亡率。
Yonsei Med J. 2022 Nov;63(11):991-998. doi: 10.3349/ymj.2022.0143.
8
Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta-Analysis.亨廷顿病的患病率和发病率:一项更新的系统评价和荟萃分析。
Mov Disord. 2022 Dec;37(12):2327-2335. doi: 10.1002/mds.29228. Epub 2022 Sep 26.
9
Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea.韩国唐氏综合征患儿急性白血病的流行病学
Cancer Res Treat. 2022 Apr;54(2):572-578. doi: 10.4143/crt.2021.368. Epub 2021 Aug 10.
10
Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers.韩国患者急性心肌梗死的当代状况:韩国区域心脑血管中心急性心肌梗死登记处
J Clin Med. 2021 Feb 1;10(3):498. doi: 10.3390/jcm10030498.
J Huntingtons Dis. 2013;2(1):83-7. doi: 10.3233/JHD-120040.
4
CAG-Expansion Haplotype Analysis in a Population with a Low Prevalence of Huntington's Disease.在亨廷顿病发病率较低的人群中进行 CAG 扩展单体型分析。
J Clin Neurol. 2014 Jan;10(1):32-6. doi: 10.3988/jcn.2014.10.1.32. Epub 2014 Jan 6.
5
De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype.由低风险单倍型上的 26-44 CAG 重复扩展引起的从头 Huntington 病。
Neurology. 2013 Sep 17;81(12):1099-100. doi: 10.1212/WNL.0b013e3182a4a4af. Epub 2013 Aug 14.
6
Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.基于普通诊所记录诊断的英国成人亨廷顿舞蹈病患病率。
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1156-60. doi: 10.1136/jnnp-2012-304636. Epub 2013 Mar 12.
7
Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?早期亨廷顿病患者大脑皮层代谢降低:疾病进展的潜在生物标志物?
J Clin Neurol. 2013 Jan;9(1):21-5. doi: 10.3988/jcn.2013.9.1.21. Epub 2013 Jan 3.
8
The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.亨廷顿病的发病率和患病率:系统评价和荟萃分析。
Mov Disord. 2012 Aug;27(9):1083-91. doi: 10.1002/mds.25075. Epub 2012 Jun 12.
9
Age-at-onset in Huntington disease.亨廷顿舞蹈症的发病年龄
PLoS Curr. 2011 Jul 29;3:RRN1258. doi: 10.1371/currents.RRN1258.
10
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.HTT 单倍型导致亨廷顿病在欧洲和东亚的患病率存在差异。
Eur J Hum Genet. 2011 May;19(5):561-6. doi: 10.1038/ejhg.2010.229. Epub 2011 Jan 19.